The Medicines and Healthcare
Products Regulatory Agency
(MHRA) said Janssen-Cilag Ltd
is recalling Doribax (doripenem)
500mg powder for solution for
infusion.
The recall was based on the
company’s portfolio review and
followed from the decision to
return the licence to Shionogi & Co
Ltd, MHRA said.
There were no known quality of
safety issues with the recall, it said.The above article was sent to subscribers in Pharmacy Daily's issue from 05 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Mar 14
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.